drugset / Trial / NCT05479474

Platelet Rich Plasma Testis Treatment for Infertile Men

NCT05479474

Recruiting 10 enrolled Stanford University
NaSingle-groupOpen-labelTreatment

Summary

Investigate the effect of intratesticular injection of autologous platelet rich plasma (PRP) on sperm retrieval rates and IVF outcomes in infertile men who already underwent a negative sperm retrieval. Currently, there is no alternative treatment after failed TESE. Prior series suggest that intratesticular PRP injections may improve TESE outcomes. We hope to determine whether PRP is an effective treatment for this patient population.

Timeline

Start
2023-01-18
Primary completion
2026-12-31
Completion
2026-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Platelet Rich Plasma Other / unclassified Other